Advertisement

Ads Placeholder
Loading...

InflaRx N.V.

IF0.DEXETRA
Healthcare
Biotechnology
2.94
0.00(0.00%)
German Market is Open • 16:44

InflaRx N.V. Fundamental Analysis

InflaRx N.V. (IF0.DE) shows weak financial fundamentals with a PE ratio of -3.78, profit margin of -676.31%, and ROE of -44.69%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

PEG Ratio-0.04
Current Ratio6.50

Areas of Concern

ROE-44.69%
Operating Margin-711.82%
We analyze IF0.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -63423.6/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-63423.6/100

We analyze IF0.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

IF0.DE struggles to generate sufficient returns from assets.

ROA > 10%
-35.49%

Valuation Score

Excellent

IF0.DE trades at attractive valuation levels.

PE < 25
-3.78
PEG Ratio < 2
-0.04

Growth Score

Weak

IF0.DE faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

IF0.DE maintains a strong and stable balance sheet.

Debt/Equity < 1
0.01
Current Ratio > 1
6.50

Profitability Score

Weak

IF0.DE struggles to sustain strong margins.

ROE > 15%
-4469.41%
Net Margin ≥ 15%
-676.31%
Positive Free Cash Flow
No

Key Financial Metrics

Is IF0.DE Expensive or Cheap?

P/E Ratio

IF0.DE trades at -3.78 times earnings. This suggests potential undervaluation.

-3.78

PEG Ratio

When adjusting for growth, IF0.DE's PEG of -0.04 indicates potential undervaluation.

-0.04

Price to Book

The market values InflaRx N.V. at 1.57 times its book value. This may indicate undervaluation.

1.57

EV/EBITDA

Enterprise value stands at -3.37 times EBITDA. This is generally considered low.

-3.37

How Well Does IF0.DE Make Money?

Net Profit Margin

For every $100 in sales, InflaRx N.V. keeps $-676.31 as profit after all expenses.

-676.31%

Operating Margin

Core operations generate -711.82 in profit for every $100 in revenue, before interest and taxes.

-711.82%

ROE

Management delivers $-44.69 in profit for every $100 of shareholder equity.

-44.69%

ROA

InflaRx N.V. generates $-35.49 in profit for every $100 in assets, demonstrating efficient asset deployment.

-35.49%

Following the Money - Real Cash Generation

Operating Cash Flow

InflaRx N.V. generates limited operating cash flow of $-30.42M, signaling weaker underlying cash strength.

$-30.42M

Free Cash Flow

InflaRx N.V. generates weak or negative free cash flow of $-30.49M, restricting financial flexibility.

$-30.49M

FCF Per Share

Each share generates $-0.69 in free cash annually.

$-0.69

FCF Yield

IF0.DE converts -29.17% of its market value into free cash.

-29.17%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-3.78

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.04

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.57

vs 25 benchmark

P/S Ratio

Price to sales ratio

2059.23

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.01

vs 25 benchmark

Current Ratio

Current assets to current liabilities

6.50

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.45

vs 25 benchmark

ROA

Return on assets percentage

-0.35

vs 25 benchmark

ROCE

Return on capital employed

-0.43

vs 25 benchmark

How IF0.DE Stacks Against Its Sector Peers

MetricIF0.DE ValueSector AveragePerformance
P/E Ratio-3.7828.54 Better (Cheaper)
ROE-44.69%738.00% Weak
Net Margin-67630.69%-43982.00% (disorted) Weak
Debt/Equity0.010.34 Strong (Low Leverage)
Current Ratio6.502806.01 Strong Liquidity
ROA-35.49%-14624.00% (disorted) Weak

IF0.DE outperforms its industry in 3 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews InflaRx N.V.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ